Susquehanna Fundamental Investments, LLC Homology Medicines, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.55 - $3.01 $36,339 - $70,569	-23,445 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $14,965 - $24,002	-5,756 Reduced 19.71%	23,445 $71,000
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $17,806 - $38,059	4,892 Added 20.12%	29,201 $106,000
Q3 2021 Nov 15, 2021	SELL	$6.01 - $8.71 $14,219 - $20,607	-2,366 Reduced 8.87%	24,309 $191,000
Q2 2021 Aug 11, 2021	BUY	$6.02 - $9.64 $76,965 - $123,247	12,785 Added 92.04%	26,675 $194,000
Q1 2021 May 17, 2021	SELL	$9.17 - $14.8 $204,646 - $330,291	-22,317 Reduced 61.64%	13,890 $131,000
Q4 2020 Feb 16, 2021	SELL	$8.92 - $13.29 $250,839 - $373,728	-28,121 Reduced 43.72%	36,207 $409,000
Q3 2020 Nov 16, 2020	BUY	$9.94 - $16.59 $267,664 - $446,735	26,928 Added 72.0%	64,328 $688,000
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $451,418 - $723,316	37,400 New	37,400 $568,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.